Chargement en cours...
The novel μ‐opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception
BACKGROUND AND PURPOSE: PZM21 is a novel μ‐opioid receptor ligand that has been reported to induce minimal arrestin recruitment and be devoid of the respiratory depressant effects characteristic of classical μ receptor ligands such as morphine. We have re‐examined the signalling profile of PZM21 and...
Enregistré dans:
| Publié dans: | Br J Pharmacol |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6003631/ https://ncbi.nlm.nih.gov/pubmed/29582414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14224 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|